Skip to content
MARKETS / NASDAQ / LFST
NASDAQ · SERVICES-HEALTH SERVICES · LARGE CAP

LifeStance Health Group, Inc. LFST

6 fiscal years on record · USD · FY2025 reported · SEC filings only
$1.4B
▲ 13.9% YoY
$9.7M
$110.0M
▲ 28.4% YoY
In brief

What this company does

Its clinicians offer patients a multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It employed 8,040 licensed mental health clinicians through its subsidiaries and supported practices in 33 states as of December 31, 2025. Its clinicians treated more than 1.0 million unique patients through approximately 9.0 million visits in 2025. It generates revenue on a per-visit basis when a patient receives care from one of its clinicians. For the year ended December 31, 2025, 90% of its revenue was derived from patients with commercial in-network payors, 5% from patients with government payors, 4% from patients on a self-pay basis and 1% from non-patient services. Patients can receive in-person care at one of its 572 centers, both acquired and new centers. As of December 31, 2025, it employed approximately 10,961 employees through its subsidiaries and supported practices, of which 4,549 were directly employed through its subsidiaries and 6,412 were directly employed by its supported practices. On January 28, 2021, LifeStance Health Group, Inc. was incorporated in the state of Delaware.

Written from the business description in LifeStance Health Group, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 25 February 2026. Every sentence was checked against that document before publication.

Growth
USD 1.4B
Revenue, FY2025 · full 6-year series below
Revenue $B Net income $B
FY2025 · Revenue 1.4 · Net income 0.0
0.5B1.0B-0.2B201920212022202320242025
Compound annual growth
+18.3%
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
1 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 1.7% · Net 0.7%
2%4%6%-20%-40%201920212022202320242025
ROE
FY2025 · ROE 0.7%
-5%-10%-15%201920212022202320242025

Each USD of equity produced 1 cents of profit this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 110.0
40M80M-40M-80M201920212022202320242025

Total assetsUSD 2.2B
EquityUSD 1.5B
CashUSD 248.6M
Gross debtUSD 280.4M
Net debtUSD 31.8M
Current ratio1.65×

Net debt stands at 2% of equity.

The 6-year record
6 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 202520242023202220212019
Revenue $B1.41.31.10.90.70.2
Operating income $B0.0−0.0−0.2−0.2−0.30.0
EBITDA $B0.10.0−0.2−0.2−0.30.0
Income tax $B0.0−0.0−0.0−0.0−0.00.0
Net income $B0.0−0.1−0.2−0.2−0.30.0
Free cash flow $B0.10.1−0.1−0.0−0.10.0
EPS, diluted $······
Dividend / sh $······
Payout %······
ROE %0.7−4.0−12.6−14.1−19.9·
Shares out B0.390.380.380.380.37·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 16 reconciliationsAUDITED

Reconciled in 6 of 19 fiscal years. 60 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Health Services
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2019

Share this section

Download image